|
Volumn 28, Issue 4, 2006, Pages 364-365
|
A novel treatment option of bipolar depression with psychotic and catatonic features
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CITALOPRAM;
CLOMIPRAMINE;
CREATINE KINASE;
FLUVOXAMINE;
HALOPERIDOL;
LORAZEPAM;
MIRTAZAPINE;
NEUROLEPTIC AGENT;
PAROXETINE;
QUETIAPINE;
VALPROIC ACID;
ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD;
AGED;
ANURIA;
AUDITORY HALLUCINATION;
BIPOLAR DEPRESSION;
CASE REPORT;
CATATONIA;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DYSPNEA;
FEMALE;
FEVER;
HALLUCINATION;
HOSPITAL ADMISSION;
HUMAN;
LETTER;
NEUROLEPTIC MALIGNANT SYNDROME;
PSYCHOSIS;
REMISSION;
SCHIZOAFFECTIVE PSYCHOSIS;
STATISTICAL SIGNIFICANCE;
TERTIARY HEALTH CARE;
TRANSCRANIAL MAGNETIC STIMULATION;
TREATMENT WITHDRAWAL;
AGED;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
CATATONIA;
CLOMIPRAMINE;
DIBENZOTHIAZEPINES;
DRUG THERAPY, COMBINATION;
FEMALE;
HALOPERIDOL;
HUMANS;
LORAZEPAM;
PAROXETINE;
PSYCHOTIC DISORDERS;
SEROTONIN UPTAKE INHIBITORS;
SYMPATHOMIMETICS;
|
EID: 33745244993
PISSN: 01638343
EISSN: None
Source Type: Journal
DOI: 10.1016/j.genhosppsych.2006.05.003 Document Type: Letter |
Times cited : (17)
|
References (8)
|